The Vascular Stent Market size in Latin America has been forecasted at USD 1.67 billion in 2022 and is projected to be growing at a CAGR of 11.5% to touch USD 2.88 billion by 2027.
Stents decrease the chance of a heart attack by assisting in keeping the coronary arteries uncluttered. The stent is implanted into the clogged artery, locking in place and bringing about the artery's opening.
A stent, once implanted, rests in the artery permanently. A jammed stent can be substituted or removed by the procedure of angiography. Stents aid in the lessening of recurring blockage or contraction after an angioplasty procedure, which comprises a plaque with an inflating helping device and is used to stretch the artery open and increase blood flow to the heart.
The growth of the Latin American Vascular Stent Market is driven by factors such as the increasing geriatric populace, the growing frequency of incidence of cardiovascular diseases, and the rising consumer and surgeon preference for stents in the place of substantially invasive procedures.
However, the Latin American Vascular Stent Market's growth is constrained by stringent government regulations and cases where the implantation of stents has failed.
This research report on the Latin American Vascular Stent Market has been segmented and sub-segmented into the following categories.
By Mode of Delivery:
By End User:
Noteworthy companies dominating the Latin American Vascular Stent Market profiled in this report are Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), and JOTEC GmbH (Germany).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org